[HTML] Effects of insulin plus glucagon-like peptide-1 receptor agonists (GLP-1RAs) in treating type 1 diabetes mellitus: a systematic review and meta-analysis
W Wang, H Liu, S Xiao, S Liu, X Li, P Yu - Diabetes Therapy, 2017 - Springer
Introduction Combination therapy with insulin and glucagon-like peptide-1 receptor agonists
(GLP-1RAs) has already been proven an efficient treatment option for type 2 diabetes. This
combination can effectively improve glycated hemoglobin levels, cause weight loss and …
(GLP-1RAs) has already been proven an efficient treatment option for type 2 diabetes. This
combination can effectively improve glycated hemoglobin levels, cause weight loss and …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com

没有评论:
发表评论